IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
Recruiting
Phase 4
Interventional Study
Heart Failure
Heart Failure With Reduced Ejection Fraction (HFrEF)
Heart Failure With Preserved Ejection Fraction (HFPEF)
Iron Deficiency
Iron-deficiency Anemia (IDA)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 250 (estimated)
- Sponsor
- Syed Hamza Mufarrih · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn which iron treatment works better for adults with congestive heart failure and low iron levels: intravenous (IV) iron given through a vein or oral (PO) iron taken by mouth. Participants must have heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF) and a transferrin-saturation (TSAT) level below 20 percent.
The mai…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* BMI ≥18.0 kg/m²
* Hemoglobin:
\> 9 g/dL and \<14 g/dL for men \> 9 g/dL and \<13 g/dL for women
* Diagnosed with Congestive Heart failure:
HFrEF: EF ≤40% in any recent echocardiogram HFpEF: EF ≥50-55% without any prior EF ≤40%, and evidence of diastolic dysf…
Contacts